The Defense Health Agency awarded a $1,159,998 Project Grant to The Cleveland Clinic Foundation to fund the "THERAPEUTIC IMMUNOSTIMULATORY MICROBES FOR TREATMENT OF OVARIAN CANCER" research project. This 4-year grant, awarded on September 1, 2024, is part of the Military Medical Research and Development program (CFDA 12.420). The project aims to develop innovative immunotherapies for ovarian cancer using microbial-based treatments. As a nationally recognized non-profit academic medical center, The Cleveland Clinic Foundation will leverage its expertise in cancer biology, immunology, and translational research to advance this critical therapeutic area for the military and broader patient population.
Generated 3/4/25, 4:42 AM